Autolus Therapeutics PLC (NAS:AUTL)
$ 3.855 0.015 (0.39%) Market Cap: 1.03 Bil Enterprise Value: 305.07 Mil PE Ratio: 0 PB Ratio: 1.76 GF Score: 55/100

Autolus Therapeutics plc - Special Call Transcript

Jun 12, 2020 / 11:30AM GMT
Release Date Price: $12.92 (-0.54%)
Operator

Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics EHA Data Update. As a reminder, this conference call is being recorded.

I would now like to turn the conference over to your host, Dr. Lucinda Crabtree, Vice President, Head of Investor Relations. Please go ahead.

Lucinda Crabtree
Autolus Therapeutics plc - VP of IR & Corporate Communications

Thank you, Michelle. Turning to Slide 2. Good morning or good afternoon, everyone, and thank you for taking part in today's call on the EHA Phase I data update. I am Lucinda Crabtree, Vice President of Investor Relations. With me today are Dr. Christian Itin, our Chairman and Chief Executive Officer; Dr. Vijay Reddy, our Chief Medical Officer; Dr. Nushmia Khokhar, our Vice President and Head of Clinical development; Brent Rice, our Chief Commercial Officer in the U.S.; and Andrew Oakley, our Chief Financial Officer.

Before we begin, I would like to remind you that during this call, we will be making forward-looking statements. All statements other than statements of historical

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot